Repros Therapeutics Market Cap:
290.85M for May 21, 2013Repros Therapeutics Historical Market Cap Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 21, 2013 | 290.85M |
| May 20, 2013 | 293.42M |
| May 17, 2013 | 311.17M |
| May 16, 2013 | 317.13M |
| May 15, 2013 | 321.98M |
| May 14, 2013 | 321.98M |
| May 13, 2013 | 329.63M |
| May 10, 2013 | 333.73M |
| May 9, 2013 | 340.81M |
| May 8, 2013 | 323.85M |
| May 7, 2013 | 352.37M |
| May 6, 2013 | 355.35M |
| May 3, 2013 | 347.34M |
| May 2, 2013 | 367.47M |
| May 1, 2013 | 354.24M |
| April 30, 2013 | 379.22M |
| April 29, 2013 | 382.95M |
| April 26, 2013 | 369.71M |
| April 25, 2013 | 374.19M |
| April 24, 2013 | 371.39M |
| April 23, 2013 | 378.29M |
| April 22, 2013 | 369.71M |
| April 19, 2013 | 363.93M |
| April 18, 2013 | 357.22M |
| April 17, 2013 | 331.12M |
| April 16, 2013 | 314.52M |
| April 15, 2013 | 304.08M |
| April 12, 2013 | 316.95M |
| April 11, 2013 | 320.49M |
| April 10, 2013 | 320.49M |
| April 9, 2013 | 304.27M |
| April 8, 2013 | 285.63M |
| April 5, 2013 | 273.51M |
| April 4, 2013 | 274.25M |
| April 3, 2013 | 289.54M |
| April 2, 2013 | 283.76M |
| April 1, 2013 | 286.93M |
| March 28, 2013 | 300.17M |
| March 27, 2013 | 170.22M |
| March 26, 2013 | 166.86M |
| March 25, 2013 | 178.80M |
| March 22, 2013 | 164.44M |
| March 21, 2013 | 177.12M |
| March 20, 2013 | 172.46M |
| March 19, 2013 | 159.87M |
| March 18, 2013 | 169.47M |
| March 15, 2013 | 175.63M |
| March 14, 2013 | 181.78M |
| March 13, 2013 | 184.58M |
| March 12, 2013 | 189.80M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
RPRX Market Cap Benchmarks
| Companies | |
|---|---|
| Biosante Pharmaceuticals | 28.09M |
| Auxilium Pharmaceuticals | 744.52M |
| Cleveland BioLabs | 72.34M |
RPRX Market Cap Rankings
| Overall |
62nd percentile 3007 of 8002 |
| Sector |
57th percentile 288 of 684 in Healthcare |
| Industry |
66th percentile 82 of 248 in Biotechnology |
RPRX Market Cap Range, Past 5 Years
| Minimum | 10.24M | Jul 7 2010 |
| Maximum | 382.95M | Apr 29 2013 |
| Average | 93.53M |
RPRX News
GlobeNewswire May 2